Karyopharm Therapeutics Inc. Insider Trading for December 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Karyopharm Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Karyopharm Therapeutics Inc. for December 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 03 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.03 | 5,000 | 165 | 2,555 | |
Dec 03 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.03 | 1,535 | 51 | 7,555 | |
Dec 03 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 45.18 | 5,000 | 225,881 | 4,262 | 9.3 K to 4.3 K (-53.98 %) |
Dec 03 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.03 | 5,000 | 165 | 9,262 | 4.3 K to 9.3 K (+117.32 %) |
Dec 03 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 41.86 | 5,000 | 209,286 | 4,262 | 9.3 K to 4.3 K (-53.98 %) |
Dec 03 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.03 | 1,535 | 51 | 9,262 | 7.7 K to 9.3 K (+19.87 %) |
Dec 01 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 41.76 | 198,115 | 8,273,223 | 9,132,700 | 9.3 M to 9.1 M (-2.12 %) |
Dec 01 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 42.18 | 25,000 | 1,054,520 | 9,330,815 | 9.4 M to 9.3 M (-0.27 %) |
Dec 01 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 42.74 | 4,094 | 174,992 | 9,355,815 | 9.4 M to 9.4 M (-0.04 %) |
Dec 01 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 42.35 | 50,906 | 2,155,925 | 9,360 | 60.3 K to 9.4 K (-84.47 %) |